Patents Examined by Ebenzer Sackey
  • Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenoreceptors
    Patent number: 7034053
    Abstract: The present invention disclosed compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: April 25, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: David N. Deaton, Barry George Shearer, David Edward Uehling
  • Compounds useful as reversible inhibitors of cysteine proteases
    Patent number: 6982272
    Abstract: Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds.
    Type: Grant
    Filed: April 24, 2003
    Date of Patent: January 3, 2006
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Michel Jose Emmanuel, Eugene R. Hickey, Weimin Liu, Denice Mary Spero, Sanxing Sun, David S. Thomson, Yancey David Ward, Erick Richard Roush Young
  • Methods and apparatus for treatment of Parkinson's disease
    Patent number: 6166081
    Abstract: A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enhancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).
    Type: Grant
    Filed: April 7, 1999
    Date of Patent: December 26, 2000
    Inventors: Moshe Kushnir, Eliahu Heldman
  • Derivatives of acrylic acid
    Patent number: 5965613
    Abstract: The present invention relates to aromatic compounds, namely substituted methyl 2-phenyl-3-methoxy-acrylates of the general formula ##STR1## where X represents an aldimino or ketimino group, in particular a group ##STR2## where R.sup.1 and R.sup.2 independently of one another denote hydrogen, C.sub.1-12 -alkyl, C.sub.1-4 -haloalkyl, and C.sub.1-4 -alkoxy-C.sub.1 -C.sub.4 -alcyl.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: October 12, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Hans P. Isenring, Stephan Trah, Bettina Drechsel